NOBIVAC® Canine 1-DAPPv
For vaccination of healthy dogs against canine distemper virus, canine adenovirus (Types 1 and 2), CPIV and CPV.
LEARN MORENobivac® Canine 1-Cv
For the vaccination of healthy dogs, designed to enhance the immune response and offer protection against canine coronavirus.
LEARN MORENobivac® 3-Rabies CA
NOBIVAC 3-RABIES CA vaccine meets state guidelines and is approved for sale in California to protect pets against rabies.
LEARN MORENOBIVAC® 3-Rabies
NOBIVAC 3-RABIES vaccine provides protection against rabies in dogs and cats for at least three years, and ferrets for one year.
LEARN MORENOBIVAC® 1-Rabies
Show effective against rabies for one year protection in healthy dogs, cats and ferrets.
LEARN MORENOBIVAC® Edge Lepto 4
NOBIVAC EDGE LEPTO4 Vaccine is the only canine leptospirosis vaccine with two critical indications, available in 0.5 mL dose.
LEARN MORENOBIVAC® Edge DAPPv+L4
NOBIVAC EDGE DAPPv+L4 provides proven protection against several common viruses and enhanced quality in leptospirosis protection.
LEARN MORENOBIVAC EDGE® DAPPv
Approved for protection of healthy dogs against canine distemper, adenovirus (Type 1), CPIV and CPV.
LEARN MOREPROTAZIL® (1.56% diclazuril) Antiprotozoal Pellets
PROTAZIL Antiprotozoal Pellets are indicated for the treatment of equine protozoal myeloencephalitis caused by Sarcocystis neurona in horses.
LEARN MOREBANAMINE®-S (flunixin meglumine injection)
For the control of pyrexia associated with swine respiratory disease.
LEARN MOREBANAMINE® TRANSDERMAL
Indicated for the control of fever associated with BRD, bovine mastitis and pain associated with foot rot. The first and only NSAID cattle…
LEARN MOREBANAMINE® (flunixin meglumine paste)
BANAMINE® (flunixin meglumine paste) is a trusted and effective treatment for musculoskeletal disorders in horses. Learn more about its uses.
LEARN MORE
Go To United States
Algeria
Argentina
Australia
Austria
Bahrain
Belgium (Dutch)
Brazil
Canada (English)
Chile
Colombia
Croatia
Czech Republic
Denmark
Ecuador
Egypt
Finland
France
Germany
Greece
Hungary
India
Indonesia
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kuwait
Lebanon
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Oman
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland (French)
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Yemen
Global